Wilmington, Delaware, United StatesFounded 202443+ employeesPrivate
$30.5M raisedSeries A· last: series a (Jan 2026)· 3 rounds
Backed by(5 investors)
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
